La leishmaniose cutanée de l’enfant : intérêt de la clarithromycine

Simple item page
dc.contributor.advisorS. AMAL
dc.contributor.authorZineb BIH
dc.date.accessioned2023-09-19T14:02:27Z
dc.date.accessioned2026-01-28T12:21:21Z
dc.date.available2023-09-19T14:02:27Z
dc.date.issued2016
dc.description.collaboratorO. HOCAR
dc.description.collaboratorN. TASSI
dc.description.collaboratorA. BOURRAHOUAT
dc.description.collaboratorG. DRAISS
dc.identifier.urihttps://toubkal.imist.ma/handle/123456789/20718
dc.identifier.urihttps://doi.org/10.83129/toubkal-1786
dc.language.isofr
dc.publisherFaculté de Médecine et de Pharmacie, Marrakechfr_FR
dc.publisherSciences médicalesfr_FR
dc.subject.otherDermatologie
dc.subject.specificLa leishmaniose cutanée
dc.subject.specificEnfant
dc.subject.specificClarithromycine
dc.titleLa leishmaniose cutanée de l’enfant : intérêt de la clarithromycinefr_FR

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
these148-16.pdf
Size:
2.64 MB
Format:
Adobe Portable Document Format
Download

Collections

Faculté de Médecine et de Pharmacie - Marrakech